Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide is a prescription-only medicine in the UK. No individual, retailer or online seller may legally supply it to another person without a valid prescription issued by a registered prescriber following a proper clinical assessment. That is not a technicality — it is a firm requirement under the Human Medicines Regulations 2012, and it applies equally to injection pens and tablets. The short answer to whether you can sell semaglutide is: only if you are a licensed pharmacy dispensing against a lawful prescription, with all the regulatory obligations that entails.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
There is a persistent idea that because semaglutide has become so widely discussed, it must sit somewhere in a grey zone, perhaps legal to share with a friend, or acceptable to sell on if you have leftover pens. That idea is wrong, and it is worth saying plainly before anything else. Semaglutide is classified as a Prescription-Only Medicine under UK law, which means the right to supply it is reserved exclusively for registered pharmacies acting on a lawful prescription. If you are wondering what selling semaglutide actually involves legally, the rules are stricter than most people expect, covering everything from informal transfers to online resale. This matters because the question of who can sell semaglutide is really a question about who bears legal and clinical responsibility for the person taking it. A GPhC-registered pharmacy operates within a framework that includes prescriber oversight, clinical checks, traceability and accountability. An individual selling online does not. The legal boundary exists for that reason, not to create bureaucracy.
If you are exploring your own access to semaglutide for weight management, the eligibility and suitability questions are the right starting point, not the supply question.
For a pharmacy or online service to sell semaglutide legally in the UK, several conditions must be met simultaneously. The pharmacy must be registered with the General Pharmaceutical Council (GPhC), you can verify any pharmacy's registration at the GPhC register. A GPhC-registered Independent Prescriber must carry out a clinical assessment of each patient. A valid prescription must exist before any medicine is dispensed. And the medicine must have been sourced through the licensed UK supply chain, not imported informally or manufactured outside authorised conditions.
Online pharmacies that meet these requirements operate within exactly the same legal framework as a high-street dispensing pharmacy. What differs is the route, the consultation happens digitally, the prescription is issued electronically, and the medicine is dispatched by a courier. None of that changes the obligation to have a proper prescription in place. At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber before anything is approved or dispatched.
The legal detail around selling semaglutide goes further than most people realise, including the implications for social-media resellers and grey-market platforms.
The Medicines and Healthcare products Regulatory Agency has been unambiguous on this. Semaglutide pens sold without a prescription (through social media, informal websites or individuals) cannot be verified as genuine. The MHRA has made large seizures of fake weight-loss pens and confirmed that some counterfeits contained insulin rather than semaglutide, creating a real risk of severe hypoglycaemia in people without diabetes. This is not a remote risk. It has caused hospitalisations.
The MHRA's public guidance notes that legitimate GLP-1 medicines are assessed for use alongside clinical oversight, not for quick or cosmetic use by anyone who can find a supplier. Buying from an unverified source sidesteps the very safeguards the prescription system is designed to provide. If you encounter a seller offering semaglutide without clinical assessment, that is a red flag. You can report suspect sellers directly at the MHRA's Yellow Card scheme.
Pricing that looks unusually low is one of the clearest warning signs. Context on what legitimate private treatment costs (and why the gap exists) is covered on the Wegovy pricing page.
This is a question our prescribers hear regularly, and it deserves a direct answer. If a person holds Wegovy pens dispensed against their own prescription, those pens are theirs for personal use only. Selling them, or giving them to someone else to use, is illegal supply of a prescription medicine. The fact that the pens were lawfully obtained in the first place makes no difference. The prescription was issued for a specific patient following a specific clinical assessment, it does not transfer with the pen.
There is a separate page that addresses whether you can sell Wegovy you already have in more detail, including the position on returns and what to do with unused medication. The practical answer on disposal is to return pens to a pharmacy, they can accept unused medicines safely.
If you are considering semaglutide for weight management through a legitimate, regulated route, Wegovy's licensing, dosing schedule and eligibility give a full picture of what a lawful private prescription pathway looks like. When you are ready to take the next step, our prescribers are available through a free consultation, reviewed the same day, with no waiting list.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.